// App-Quantinova.ai

P255 : Perceived disease severity and treatment satisfaction among patients with ulcerative colitis in Europe

Researchers

Presenter

  • A Armuzzi

Principal Investigators

  • M Tarallo

  • D Bargo

  • J Lucas

  • D Bluff

  • B Hoskin

  • L Salese

  • J Cappelleri

  • C Kayhan

  • M DiBonaventura

Medical Centers

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Universita Cattolica del Sacro Cuore, Rome, Italy

  • Pfizer Inc., Rome, Italy

  • Pfizer Inc, New York, NY

  • Adelphi Real World, Maccelsfield, UK

  • Pfizer Inc, Collegeville, PA

  • Pfizer, Groton, CT

  • Pfizer Inc, Patient & Health Impact, New York, U.S.A

Locations

  • Italy

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Autoimmune (AI)

  • Genetic Disorder

  • Gastroenterology (GU)

Disease

  • Inflammatory bowel disease

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved